Trademark: 98745222
Word
AMLOGENYX
Status
Pending
Status Code
630
Status Date
Wednesday, September 11, 2024
Serial Number
98745222
Mark Type
4
Filing Date
Wednesday, September 11, 2024

Trademark Owner History

Classifications
42 Pharmaceutical, scientific, and medical research and development in the field of gene therapy manufacturing technology; biomedical and scientific research in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic diseases and disorders, neurological diseases and disorders, gene therapy, and cell therapy; biomedical research in the field of gene therapy design and delivery; gene therapy design and delivery development of biochemical assays; product development in the fields of genetic therapies and effectors to regulate, modulate, and characterize disease states; pharmaceutical research and development in the field of gene therapy; scientific research in the nature of conducting clinical trials for others in the field of gene therapy design and delivery; scientific and medical research, namely, compiling and sharing of patient data for research purposes in the field of neurological and genetic diseases and disorders; medical and scientific research information in the field of neurological and genetic diseases and disorders; providing medical research and scientific research information in the field of neurological and genetic diseases and disorders; providing medical research and scientific research information in the field of gene therapies

Trademark Events
Sep 11, 2024
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24